Navigation Links
Final agenda available for CTO and Left Main Summit to be held Feb. 21-23, 2013 in NYC
Date:2/13/2013

WHAT:

The final agenda for the Chronic Total Occlusion and Left Main Summit has been set and is now available at: http://www.complexpci.com/conference/agenda.html.

The three-day conference will feature state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions and left main coronary interventions. Topics at this year's summit will include:

  • Fundamentals of CTO PCI

  • Complex Retrograde and Antegrade CTO PCI

  • Updates on Global CTO Registries

  • Left Main PCI: Essential Knowledge

  • Left Main Publications and Abstracts

  • Complication Prevention and Management

  • How to Improve Outcomes

  • Live Case Transmissions

  • Edited Taped Case Presentations

WHY:

A complete blockage in the coronary artery lasting more than three months, or chronic total occlusion (CTO), has historically been one of the most challenging types of blockages to treat with an interventional procedure. Leading practitioners of percutaneous coronary intervention (PCI) must become experts at restoring blood flow for patients with chronic total occlusions, and with advanced techniques, success rates greater than 90% may be obtained.

Stenting of the unprotected left main coronary artery has also emerged as a viable alternative to surgery in selected patients but requires a special skill set and understanding of anatomy, imaging, hemodynamic support, and adjunctive devices.

This year's conference will emphasize both advanced techniques and evidence-based medicine, along with live case transmissions featuring the world's leading experts in left main and CTO stenting.

WHEN:

February 21-23, 2013

WHERE:

New York Marriott Marquis Hotel
New York, NY

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Pixel Film Studios Releases ProDust Composite Footage Package for Final Cut Pro X
2. Finally! An Answer To A Good Nights Sleep
3. ProRain Plugin for Final Cut Pro X Released by Pixel Film Studio Today
4. Final agenda available for CRF sponsored conference on stem cell therapy for heart disease
5. The Final Release of Plexxis Drywall Construction Estimating Software is January, 2013
6. Newly Released ProSkin 2.0 and ProMood Final Cut Pro X Plugins at Pixel Film Studios
7. Study demonstrates that earlier end of life care discussions are linked to less aggressive care in final days of life
8. The cells petrol pump is finally identified
9. Agenda set for upcoming CRF-sponsored conference on stem cell therapy for heart disease
10. Refinery Catalyst Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
11. New DIY Custom Clock Now Available at Contemporary Heaven
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & ... (TGIG), has initiated cultivation and processing operations at its production facility, and opened ... , Puradigm is the manufacturer of a complete system of proactive air and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology: